Echo Therapuetics
Tags: diabetes, Echo Therapuetics, ECTE, ECTE.ob, Glucose Monitoring
Echo Therapeutics is a transdermal medical device and specialty pharmaceuticals company. Echo’s Symphony™ tCGM System is a non-invasive (needle-free), wireless, transdermal continuous glucose monitoring (tCGM) system focused on changing the paradigm of invasive, episodic glucose testing in diabetes home use and hospital critical care markets.
Echo’s AzoneTS™ transdermal drug reformulation technology is focused on building a pipeline of safer and improved versions of widely-prescribed, FDA-approved specialty pharmaceutical products. Echo is developing most of its AzoneTS pipeline in accordance with the FDA’s Section 505(b)(2) guidelines. Durhalieve™, Echo’s lead AzoneTS drug candidate, is an advanced topical reformulation of triamcinolone acetonide for treatment of corticosteroid responsive dermatoses. Echo has submitted its Durhalieve New Drug Application (NDA) to the FDA.
NewsletterNo Newsletters found. |
Recent Blog EntriesEcho Therapeutics Cornerstone Product Featured in Scientific American MagazinePosted Thursday, April 22nd, 2010
Echo Therapeutics, Inc. (OTCBB: ECTE) - a stock that I personally thought would be trading above $2 by now, recently had its Symphony™ trans-dermal Glucose monitoring system was featured in a March 31, 2010 online magazine article in Scientific A... LifeTech Capital Initiates Echo Therapeutics (ECTE) with Strong Speculative Buy $4.50 TargetPosted Thursday, January 21st, 2010
Click Here to View Report/Buy Recommendation... ECTE Breaks 52-Week High and Poised to Move HigherPosted Thursday, January 14th, 2010
Echo Therapeutics, Inc. (OTCBB: ECTE) is poised to move higher. By hitting a new 52-week high, ECTE has triggered major accumulation among traders and things are heating up. Remember, there are countless indicators that are very optimistic regar... Check Out ECTE’s Presentation from OneMed Finance ForumPosted Thursday, January 14th, 2010
Here's a link to Echo Therapeutics (OTCBB: ECTE) CEO Patrick H. Mooney, M.D's presentation this week at the OneMed Finance Forum in San Francisco: http://www.ustream.tv/recorded/3953983
This gives a gret description of the company, its key product... ECTE Exhibiting a Strong Upward TrendPosted Wednesday, January 13th, 2010
Echo Therapeutics, Inc. (OTCBB: ECTE) made it to new 18 month highs yesterday, hitting $2.04 at one point and closing at a new 52 week high of $2.02. Pre-market trading is looking strong so far at $2.06 We suspect there will be excitement at the open... |

Keep an eye on SMC Recordings Inc. (SMCE.PK) for tomorrow. It closed today $1.11 today (Tuesday) and snuck some news out at close. Last time we witnessed this stock double within a day, so it’s likely traders will remember this and jump on the bandwagon again. If this breaks $1.25 in early trading tomorrow this could test $1.50 by mid day. Do remember to take profits along the way, if it jumps too quickly out of the gate watch for a pull back entry.
More about this pick »
OutcastTrader is a leading research and analysis firm, dedicated to locating and tracking a select few small-cap companies with exceptional investment potential. With over 25 years in the trading and investment industry, our team is adept at identifying companies poised for significant growth. The companies monitored are meticulously analyzed by our research team and chosen based upon: fundamental value, dynamic service and/or product, and potential growth in the ever changing marketplace. Despite the excellent appreciation potential, many of these smaller companies are unknown to the mainstream investment community. We serve the whole gamut of investors, from the corporate client to mainstream investment firms, and offer multiple mediums of research ranging from company profiles to statistics, trading picks to complete research reports.